Chemical modification of ascorbic acid and evaluation of its lipophilic derivatives as inhibitors of secretory phospholipase A2 with anti-inflammatory activity

Riyaz Mohamed, K. K. Dharmappa, Shaista Tarannum, N. M. Jameel, S. A. Kannum, H. S. Ashrafulla, Lokanath Rai, Cletus Jmd Souza, M. A. Shekhar, Bannikuppe S. Vishwanath

Research output: Contribution to journalArticle

13 Citations (Scopus)

Abstract

The halo 6-fatty acid esters of l-ascorbic acid 3a, 3b and 6-fatty acid esters of l-ascorbic acid 5a-g were achieved from l-ascorbic acid 1. Compounds 3a, 3b and 5a-g were evaluated for anti-oxidant, anti-lipid peroxidation, and secretory phospholipase A2 (sPLA2) inhibition in vitro, and sPLA2 induced mouse paw edema. All the derivatives retained their anti-oxidant property compared to ascorbic acid at 6 × 10-4M and are good inhibitors of lipid peroxidation at 1 mg ml-1 as evaluated by 2, 2-Diphenyl-1-picrylhydrazyl radical and thio-barbituric acid methods, respectively. Compounds 5e and 5f significantly inhibited purified group I sPLA2 from Naja naja and group II sPLA2 from Vipera russelli, human synovial fluid and human pleural fluid with IC 50 value ranging from 64 ± 1.95 to 82 ± 1.3 and 48 ± 2.27 to 61 ± 2.23 μM, respectively. The compounds 5e and 5f also showed varying degree of potency in neutralizing indirect hemolytic activity of sPLA2 at 50 μM concentration, and sPLA2 induced mouse paw edema at the dose 3 mg/kg. Further docking studies also confirmed that compounds 5e and 5f have maximum interaction with increasing negative energy value. Single molecule possessing both anti-oxidant and anti-inflammatory activities is of great therapeutic significance in inflammatory disorders.

Original languageEnglish (US)
Pages (from-to)69-76
Number of pages8
JournalMolecular and Cellular Biochemistry
Volume345
Issue number1-2
DOIs
StatePublished - Dec 1 2010

Fingerprint

Secretory Phospholipase A2
Chemical modification
Ascorbic Acid
Anti-Inflammatory Agents
Derivatives
Oxidants
Group I Phospholipases A2
Edema
Esters
Fatty Acids
Group II Phospholipases A2
Elapidae
Fluids
Synovial Fluid
Lipid Peroxidation
Lipids
Molecules

Keywords

  • 6-fatty acid esters of l-ascorbic acid
  • Anti-inflammatory activity
  • Anti-oxidant
  • Docking
  • SPLA

ASJC Scopus subject areas

  • Molecular Biology
  • Clinical Biochemistry
  • Cell Biology

Cite this

Chemical modification of ascorbic acid and evaluation of its lipophilic derivatives as inhibitors of secretory phospholipase A2 with anti-inflammatory activity. / Mohamed, Riyaz; Dharmappa, K. K.; Tarannum, Shaista; Jameel, N. M.; Kannum, S. A.; Ashrafulla, H. S.; Rai, Lokanath; Souza, Cletus Jmd; Shekhar, M. A.; Vishwanath, Bannikuppe S.

In: Molecular and Cellular Biochemistry, Vol. 345, No. 1-2, 01.12.2010, p. 69-76.

Research output: Contribution to journalArticle

Mohamed, R, Dharmappa, KK, Tarannum, S, Jameel, NM, Kannum, SA, Ashrafulla, HS, Rai, L, Souza, CJ, Shekhar, MA & Vishwanath, BS 2010, 'Chemical modification of ascorbic acid and evaluation of its lipophilic derivatives as inhibitors of secretory phospholipase A2 with anti-inflammatory activity', Molecular and Cellular Biochemistry, vol. 345, no. 1-2, pp. 69-76. https://doi.org/10.1007/s11010-010-0561-z
Mohamed, Riyaz ; Dharmappa, K. K. ; Tarannum, Shaista ; Jameel, N. M. ; Kannum, S. A. ; Ashrafulla, H. S. ; Rai, Lokanath ; Souza, Cletus Jmd ; Shekhar, M. A. ; Vishwanath, Bannikuppe S. / Chemical modification of ascorbic acid and evaluation of its lipophilic derivatives as inhibitors of secretory phospholipase A2 with anti-inflammatory activity. In: Molecular and Cellular Biochemistry. 2010 ; Vol. 345, No. 1-2. pp. 69-76.
@article{045ec89f9cc94febbfade45a86199bba,
title = "Chemical modification of ascorbic acid and evaluation of its lipophilic derivatives as inhibitors of secretory phospholipase A2 with anti-inflammatory activity",
abstract = "The halo 6-fatty acid esters of l-ascorbic acid 3a, 3b and 6-fatty acid esters of l-ascorbic acid 5a-g were achieved from l-ascorbic acid 1. Compounds 3a, 3b and 5a-g were evaluated for anti-oxidant, anti-lipid peroxidation, and secretory phospholipase A2 (sPLA2) inhibition in vitro, and sPLA2 induced mouse paw edema. All the derivatives retained their anti-oxidant property compared to ascorbic acid at 6 × 10-4M and are good inhibitors of lipid peroxidation at 1 mg ml-1 as evaluated by 2, 2-Diphenyl-1-picrylhydrazyl radical and thio-barbituric acid methods, respectively. Compounds 5e and 5f significantly inhibited purified group I sPLA2 from Naja naja and group II sPLA2 from Vipera russelli, human synovial fluid and human pleural fluid with IC 50 value ranging from 64 ± 1.95 to 82 ± 1.3 and 48 ± 2.27 to 61 ± 2.23 μM, respectively. The compounds 5e and 5f also showed varying degree of potency in neutralizing indirect hemolytic activity of sPLA2 at 50 μM concentration, and sPLA2 induced mouse paw edema at the dose 3 mg/kg. Further docking studies also confirmed that compounds 5e and 5f have maximum interaction with increasing negative energy value. Single molecule possessing both anti-oxidant and anti-inflammatory activities is of great therapeutic significance in inflammatory disorders.",
keywords = "6-fatty acid esters of l-ascorbic acid, Anti-inflammatory activity, Anti-oxidant, Docking, SPLA",
author = "Riyaz Mohamed and Dharmappa, {K. K.} and Shaista Tarannum and Jameel, {N. M.} and Kannum, {S. A.} and Ashrafulla, {H. S.} and Lokanath Rai and Souza, {Cletus Jmd} and Shekhar, {M. A.} and Vishwanath, {Bannikuppe S.}",
year = "2010",
month = "12",
day = "1",
doi = "10.1007/s11010-010-0561-z",
language = "English (US)",
volume = "345",
pages = "69--76",
journal = "Molecular and Cellular Biochemistry",
issn = "0300-8177",
publisher = "Springer Netherlands",
number = "1-2",

}

TY - JOUR

T1 - Chemical modification of ascorbic acid and evaluation of its lipophilic derivatives as inhibitors of secretory phospholipase A2 with anti-inflammatory activity

AU - Mohamed, Riyaz

AU - Dharmappa, K. K.

AU - Tarannum, Shaista

AU - Jameel, N. M.

AU - Kannum, S. A.

AU - Ashrafulla, H. S.

AU - Rai, Lokanath

AU - Souza, Cletus Jmd

AU - Shekhar, M. A.

AU - Vishwanath, Bannikuppe S.

PY - 2010/12/1

Y1 - 2010/12/1

N2 - The halo 6-fatty acid esters of l-ascorbic acid 3a, 3b and 6-fatty acid esters of l-ascorbic acid 5a-g were achieved from l-ascorbic acid 1. Compounds 3a, 3b and 5a-g were evaluated for anti-oxidant, anti-lipid peroxidation, and secretory phospholipase A2 (sPLA2) inhibition in vitro, and sPLA2 induced mouse paw edema. All the derivatives retained their anti-oxidant property compared to ascorbic acid at 6 × 10-4M and are good inhibitors of lipid peroxidation at 1 mg ml-1 as evaluated by 2, 2-Diphenyl-1-picrylhydrazyl radical and thio-barbituric acid methods, respectively. Compounds 5e and 5f significantly inhibited purified group I sPLA2 from Naja naja and group II sPLA2 from Vipera russelli, human synovial fluid and human pleural fluid with IC 50 value ranging from 64 ± 1.95 to 82 ± 1.3 and 48 ± 2.27 to 61 ± 2.23 μM, respectively. The compounds 5e and 5f also showed varying degree of potency in neutralizing indirect hemolytic activity of sPLA2 at 50 μM concentration, and sPLA2 induced mouse paw edema at the dose 3 mg/kg. Further docking studies also confirmed that compounds 5e and 5f have maximum interaction with increasing negative energy value. Single molecule possessing both anti-oxidant and anti-inflammatory activities is of great therapeutic significance in inflammatory disorders.

AB - The halo 6-fatty acid esters of l-ascorbic acid 3a, 3b and 6-fatty acid esters of l-ascorbic acid 5a-g were achieved from l-ascorbic acid 1. Compounds 3a, 3b and 5a-g were evaluated for anti-oxidant, anti-lipid peroxidation, and secretory phospholipase A2 (sPLA2) inhibition in vitro, and sPLA2 induced mouse paw edema. All the derivatives retained their anti-oxidant property compared to ascorbic acid at 6 × 10-4M and are good inhibitors of lipid peroxidation at 1 mg ml-1 as evaluated by 2, 2-Diphenyl-1-picrylhydrazyl radical and thio-barbituric acid methods, respectively. Compounds 5e and 5f significantly inhibited purified group I sPLA2 from Naja naja and group II sPLA2 from Vipera russelli, human synovial fluid and human pleural fluid with IC 50 value ranging from 64 ± 1.95 to 82 ± 1.3 and 48 ± 2.27 to 61 ± 2.23 μM, respectively. The compounds 5e and 5f also showed varying degree of potency in neutralizing indirect hemolytic activity of sPLA2 at 50 μM concentration, and sPLA2 induced mouse paw edema at the dose 3 mg/kg. Further docking studies also confirmed that compounds 5e and 5f have maximum interaction with increasing negative energy value. Single molecule possessing both anti-oxidant and anti-inflammatory activities is of great therapeutic significance in inflammatory disorders.

KW - 6-fatty acid esters of l-ascorbic acid

KW - Anti-inflammatory activity

KW - Anti-oxidant

KW - Docking

KW - SPLA

UR - http://www.scopus.com/inward/record.url?scp=78449302830&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=78449302830&partnerID=8YFLogxK

U2 - 10.1007/s11010-010-0561-z

DO - 10.1007/s11010-010-0561-z

M3 - Article

C2 - 20730622

AN - SCOPUS:78449302830

VL - 345

SP - 69

EP - 76

JO - Molecular and Cellular Biochemistry

JF - Molecular and Cellular Biochemistry

SN - 0300-8177

IS - 1-2

ER -